‘Chemobrain’: Neuroimmunological Consequences of Chemotherapy-induced Mucositis and Opioid Palliation in Development of the Condition
‘Chemobrain’: Neuroimmunological Consequences of Chemotherapy-induced Mucositis and Opioid Palliation in Development of the Condition
批准号:
nhmrc : GNT1140072
负责人:
Dr Alexandra Whittaker
金额:
$31.88万
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --
来源:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Approximately 46% of cancer patients receiving chemotherapy will experience cognitive impairment. The development of this condition may be linked to another common gut side-effect of chemotherapy- mucositis. The treatment of mucositis pain by potent paink
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金